ZDHHC6 inhibitors belong to a distinct chemical class that specifically targets the enzyme zinc finger DHHC-type containing 6 (ZDHHC6). ZDHHC6 is a member of the DHHC family of palmitoyl acyltransferases, playing a crucial role in the dynamic post-translational modification known as palmitoylation. Palmitoylation involves the reversible attachment of fatty acids, such as palmitate, to cysteine residues of proteins, and it serves as a key regulator of protein localization, stability, and function within the cellular membrane. ZDHHC6, in particular, is implicated in the palmitoylation of various substrate proteins, including members of the PSD-95/Dlg/ZO-1 (PDZ) domain-containing family, and its inhibition holds promise for modulating cellular processes governed by palmitoylation.
ZDHHC6 inhibitors typically comprises small molecules designed to selectively bind to the catalytic site of ZDHHC6, thereby impeding its enzymatic activity. By obstructing the palmitoylation process mediated by ZDHHC6, these inhibitors exert influence over the subcellular distribution and interactions of palmitoylated proteins. As a consequence, ZDHHC6 inhibitors have the potential to contribute to a better understanding of the intricate mechanisms underlying cellular signaling pathways and may serve as valuable tools for elucidating the physiological consequences of altered palmitoylation patterns. Research into ZDHHC6 inhibitors is actively pursued to uncover the intricacies of palmitoylation-dependent processes, opening avenues for the exploration of novel molecular targets and biological pathways that could be harnessed for various scientific investigations.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
2-Bromohexadecanoic acid | 18263-25-7 | sc-251714 sc-251714A | 10 g 50 g | $53.00 $201.00 | 4 | |
A palmitic acid analog that can inhibit palmitoyltransferases, potentially reducing the activity of ZDHHC6. | ||||||
Cerulenin (synthetic) | 17397-89-6 | sc-200827 sc-200827A sc-200827B | 5 mg 10 mg 50 mg | $161.00 $312.00 $1210.00 | 9 | |
An inhibitor of fatty acid synthase that may decrease the availability of palmitoyl-CoA, a substrate of ZDHHC6. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
An N-glycosylation inhibitor that can disrupt protein folding, possibly affecting ZDHHC6 function. | ||||||
PF-429242 | 947303-87-9 | sc-507498 | 5 mg | $176.00 | ||
An inhibitor of S1P protease which may indirectly influence ZDHHC6 by affecting the sphingolipid metabolism. | ||||||
Decylubiquinone | 55486-00-5 | sc-358659 sc-358659A | 10 mg 50 mg | $70.00 $269.00 | 10 | |
An analog of ubiquinone that can influence electron transport and cellular redox states, indirectly affecting ZDHHC6. | ||||||
Triacsin C Solution in DMSO | 76896-80-5 | sc-200574 sc-200574A | 100 µg 1 mg | $187.00 $843.00 | 14 | |
An inhibitor of long-chain acyl-CoA synthetase, which may reduce the availability of substrates for ZDHHC6. | ||||||
Fumonisin B1 | 116355-83-0 | sc-201395 sc-201395A | 1 mg 5 mg | $200.00 $680.00 | 18 | |
A disruptor of sphingolipid biosynthesis which might alter cellular pathways involving ZDHHC6. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $203.00 $611.00 | 24 | |
A neutral sphingomyelinase inhibitor which may impact signaling pathways associated with ZDHHC6. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
An inhibitor of Ras farnesyltransferase that could affect proteins in the same pathways as ZDHHC6. | ||||||